SPECTRUM BRANDS HOLDINGS, INC. (SPB)
Hold

Fiscal 2026 Delivers, but the Helen of Troy Bid Points Spectrum's Cash at the Business It Meant to Exit

Published: By A.N. Burrows SPB | Q4 FY2026 Earnings Analysis

Key Takeaways

  • Spectrum met or beat each of its fiscal 2026 financial targets. Adjusted EBITDA excluding tariff refunds rose 9.8% to $317.4M, against a mid-single-digit framework and our $305M estimate. Adjusted free cash flow excluding refunds was $188.2M, versus our $152.5M, and net debt fell to $289.9M (0.77x).
  • The fourth-quarter beat was thinner than the headline. Q4 adjusted EBITDA excluding refund costs rose 15.3%, but Spectrum's EBITDA keeps interest income inside it, and $8.4M of the $9.7M gain came from interest income and lower non-operating expense. On an operating basis, the gain was 1.9%. Adjusted EPS of $1.39 beat the $0.90–0.93 consensus because of a tax benefit. At next year's 27.1% rate, the quarter earns about $0.94.
  • The fiscal 2027 framework is credible but modest. Management guides sales and normalized EBITDA flat to up low single digits, and it plans to absorb about $80M of new input-cost inflation. The first half carries known drags: garden retailer inventory and the reversal of about $7M of HPC orders pulled into Q4.
  • The Helen of Troy bid changes the HPC pillar. Empower Brands, the HPC business Spectrum owns with Oaktree, offered $37 a share (about $1.6B of enterprise value, 7.7x Helen of Troy's own EBITDA guide). Helen of Troy's board rejected the offer twice. Funding needs new Spectrum equity, which turns a planned exit into a build-up first.
  • Rating: Maintaining Hold. We now value Spectrum on operating EBITDA, which removes interest income that the net-debt line already credits. Our base value stays about $94, an 8.9% total return from $87.85 against our 8% market hurdle. Price discipline on Helen of Troy is now the main swing factor in either direction.

Results vs. Consensus

Spectrum reported before the market opened on November 12. The quarter ended September 30, 2026.

Q4 FY26 metricActualConsensusBeat/MissMagnitude
Net sales$713.2M$718.0–721.2MMiss($4.8–8.0M), 0.7–1.1%
Adjusted diluted EPS, as reported$1.39$0.90–0.93Beat+$0.46–0.49
Adjusted EPS at the 27.1% FY27 tax rate (analyst)~$0.94$0.90–0.93In line+$0.01–0.04
GAAP diluted EPS, continuing operations$1.08n/an/a$2.19 a year ago
Gross margin, reported / excluding refund cost37.6% / 38.1%n/an/a+260bps / +310bps YoY
Adjusted EBITDA, excluding refund costs$73.1Mn/an/a+15.3% YoY
Adjusted EBITDA, operating basis, excluding refund costs (analyst)$68.8Mn/an/a+1.9% YoY

No Q4 EBITDA consensus was available to us. The table below compares EBITDA and free cash flow with the estimates we published in August.

Q4 FY26 metricActualOur August estimateDifference
Net sales$713.2M$709.8M+$3.4M
Adjusted EBITDA, excluding refund costs$73.1M$60.7M+$12.4M
Adjusted free cash flow, excluding refunds (analyst)~$55M~$19M+~$36M

Year-over-year comparison: fourth quarter

MetricQ4 FY25Q4 FY26YoY change
Net sales$733.5M$713.2M-2.8% (organic -3.1%)
Gross profit$256.6M$268.4M+4.6%
Gross margin35.0%37.6%+260bps
SG&A$226.3M$244.0M+7.8%
Operating income$29.4M$24.4M-17.0%
Interest income$0.6M$4.8M+$4.2M
Income tax expense (benefit)($35.9M)($6.3M)Benefit $29.6M smaller
Net income, continuing operations$53.3M$26.4M-50.5%
GAAP diluted EPS, continuing operations$2.19$1.08-50.7%
Adjusted EBITDA, as reported$63.4M$69.9M+10.3%
Adjusted EBITDA, excluding refund costs$63.4M$73.1M+15.3%
Adjusted diluted EPS$2.61$1.39-46.7%
Diluted shares24.3M23.2M-4.5%

Sequential comparison

Q3 is the garden peak, so the sequential decline is mostly seasonal.

MetricQ3 FY26Q4 FY26QoQ change
Net sales$753.3M$713.2M-5.3%
Gross margin, excluding refund effects41.1%38.1%-300bps
Operating income$15.9M$24.4M+53.5%
Adjusted EBITDA, excluding refund effects$97.7M$73.1M-25.2%
GAAP diluted EPS, continuing operations($1.11)$1.08Q3 carried a $104M impairment
Adjusted diluted EPS, as reported$2.79$1.39Q3 included $1.90 of refunds

Fiscal year comparison

MetricFY25FY26YoY change
Net sales$2,809.0M$2,852.4M+1.5% (organic -0.3%)
Gross margin, reported36.7%40.3%+360bps
Gross margin, excluding net refunds36.7%38.3%+160bps
Operating income$124.9M$110.9M-11.2%
Net income, continuing operations$100.2M$58.0M-42.1%
GAAP diluted EPS, continuing operations$3.85$2.20-42.9%
Adjusted EBITDA, as reported$289.1M$374.8M+29.6%
Adjusted EBITDA, excluding net refunds$289.1M$317.4M+9.8%
Adjusted EBITDA, operating basis, excluding net refunds (analyst)$296.8M$311.5M+5.0%
Adjusted diluted EPS, as reported$5.43$6.80+25.2%
Adjusted free cash flow, as reported$170.7M$247.3M+44.9%
Adjusted free cash flow, excluding refunds$170.7M$188.2M+10.3%
Quality of the beat: The year was better than the quarter. Fiscal 2026 EBITDA excluding refunds beat the raised framework, and cash flow beat it by more. In Q4, almost all of the EBITDA gain came from below the operating line, and almost all of the EPS beat came from tax. The gross-margin progress is real, but higher investment spending absorbed it in the quarter.

Revenue assessment: Sales fell 2.8%, about 1% below consensus and $3.4M above our own $709.8M estimate. Home & Garden caused most of the decline. Its sales fell $12.9M as retailers sold down the inventory they built against a strong April. That was the risk we flagged in August, and it arrived on schedule. Pet care beat our number because North America grew against last year's deferred shipments. HPC was in line, but about $7M of it was European retailers ordering ahead of the ERP go-live. Excluding that pull-forward, HPC sales fell about 3%. The quarter therefore holds no new demand problem, but it holds a little borrowed revenue.

Margin assessment: Gross margin rose 310bps excluding the $3.2M refund-related supply-chain cost, on pricing, lower trade spend, lower tariff rates and cost actions. SG&A rose 7.8% as investment spending stepped up. Operating income therefore fell $5.0M. The EBITDA line tells a better story only because of how Spectrum defines it. The company adds back interest expense but keeps interest income and other non-operating items. Interest income rose $4.2M and other non-operating expense fell $4.2M. Together they supplied $8.4M of the $9.7M gain. On an operating basis, Q4 EBITDA excluding refund costs grew 1.9%, to $68.8M from $67.5M. For the full year, the same correction cuts underlying growth from 9.8% to 5.0%. Five percent is still the mid-single-digit growth management promised in August. It is not the near-10% the headline suggests.

EPS assessment: Adjusted EPS of $1.39 included an adjusted tax benefit of about $2.4M, a negative rate near 8%, on $30.0M of adjusted pre-tax income. At the 27.1% rate management uses for fiscal 2027, the same pre-tax income gives about $0.94, in line with the $0.90–0.93 consensus. A lower share count helped: diluted shares fell 4.5% year over year. Management named the year-over-year cut in tax benefits as the reason adjusted EPS fell from $2.61. That is the right reading, and it applies in reverse to the beat. Tax items have shaped the headline adjusted EPS in four of the five quarters we have covered since Q4 FY25. Q2 FY26 was the only clean one.

Segment Performance

Segment EBITDA below excludes the $3.2M of tariff-refund-related costs in Q4 (pet $2.4M, HPC $0.8M). Garden carried none.

SegmentQ4 salesReported / organic growthAdjusted EBITDA, excl. refund costsMargin (YoY)vs. our estimateNotable
Global Pet Care$293.5M-1.5% / -1.1%$48.2M16.4% (-20bps)+$6.5M salesNorth America up low single digits on a hard comparison
Home & Garden$126.3M-9.3% / -9.3%$13.3M10.5% (-160bps)($2.7M) salesRetailer inventory payback, as flagged
Home & Personal Care$293.4M-0.9% / -2.3%$25.7M8.8% (+350bps)($0.4M) salesMargin gain; ~$7M ERP order pull-forward
Consolidated$713.2M-2.8% / -3.1%$73.1M10.2% (+160bps)+$3.4M salesIncludes corporate and non-operating items

Full-year segment mix

SegmentFY26 salesReported growthOrganic growthShare of salesFY27 sales outlook
Global Pet Care$1,138.1M+5.1%+3.7%39.9%Low-single-digit growth; margins in line
Home & Garden$594.9M+3.9%+3.8%20.9%Low-single-digit growth; first half soft
Home & Personal Care$1,119.4M-3.0%-6.1%39.2%Relatively flat; margins pressured
Total$2,852.4M+1.5%-0.3%100%Flat to up low single digits

Global Pet Care: a volume-led year with a softer exit

Pet sales grew 5.1% for the year, a return to growth that management says came from volume. The fourth quarter was weaker, as August had warned. Sales fell 1.5%, and organic sales fell 1.1%. North America still grew low single digits against last year's stop-ship catch-up, with chews, stain-and-odor and grooming holding or gaining share. Europe fell mid single digits against last year's Eukanuba launch orders. North American aquatics fell low double digits, mostly from lost distribution in hard goods.

"In North America, sales increased low-single digits, a result made more notable as we were lapping elevated prior-year volume tied to a stop-ship event that shifted orders from Q3 into Q4 of last year, affecting results across the segment."
— Faisal Qadir, CFO

Margin excluding refund costs slipped 20bps to 16.4%. Pricing, mix and cost actions nearly covered lower volume and higher investment spending. For fiscal 2027, management expects low-single-digit sales growth and margins in line with this year, despite inflation.

Assessment: The pet pillar passed its fiscal 2026 test. Growth survived both timing reversals we expected, and the decline in Q4 came from comparisons we had already named. The weak spot is aquatics, now less than a fifth of the business by management's account. A North American Tetra turnaround is a plan, not yet a result. We model pet sales up 2.5% in fiscal 2027.

Home & Garden: the inventory payback arrives, and part of it rolls into fiscal 2027

Garden sales fell 9.3%, a little below our $129M estimate. Controls fell double digits after the record third quarter. Weather stayed unfavorable through August before improving in September, and retailers worked through the stock they had bought against April. Spectracide, Hot Shot and Repel still gained share. EBITDA fell $3.6M to $13.3M on lower volume, partly offset by productivity.

"As we enter fiscal 2027, retailers made progress working through elevated inventory levels during the fourth quarter, though some excess remains. We expect the inventory overhang to be largely resolved in the first half of the fiscal year, resulting in generally healthy levels by the start of the season."
— Faisal Qadir, CFO

For the year, garden sales grew 3.9% and margin improved 100bps excluding refunds. Management expects low-single-digit growth in fiscal 2027, helped by the second year of distribution for the liquid lawn fertilizer.

Assessment: The channel did not exit clean, which was one of our two conditions for a better rating. The excess is now a first-half issue rather than a season issue, and the first half is the staging period for garden anyway. We assume flat garden sales in the first half and growth in the season. If retailers still hold excess stock when the season begins, the fiscal 2027 garden plan would be at risk.

Home & Personal Care: the profit target is met; sales repair is not

HPC delivered $68.9M of EBITDA excluding refunds for the year, a 6.2% margin, up 130bps. That beat the $60M-plus aspiration we have tracked since management chose to run the business for profit. Q4 EBITDA excluding refund costs rose $10.0M to $25.7M, on lower tariff rates, efficiencies and currency. Sales tell a different story. North America fell low double digits after distribution losses in appliances and new competition in personal care. Europe's low-single-digit organic growth leaned on about $7M of orders that retailers placed ahead of the ERP go-live.

"Results benefited from approximately $7 million of retailer order accelerations ahead of our S/4HANA ERP go-live, which contributed favorably to the quarter."
— Faisal Qadir, CFO

Management guides HPC sales relatively flat in fiscal 2027 and expects inflation to pressure its margins.

Assessment: HPC is a better-run business than a year ago. It is not yet a growing one, and the first quarter must absorb the $7M pull-forward. That matters more now, because HPC is the platform Empower Brands wants to enlarge with Helen of Troy. We hold HPC sales flat and its EBITDA slightly lower in fiscal 2027.

Key KPIs

KPIQ4 / FY26ComparisonTrendvs. expectation
Adjusted FCF excluding refunds, FY$188.2M$170.7M in FY25 (all-in)UpAbove our $152.5M
FCF conversion excluding refunds, FY59.3%~50% frameworkUpAbove
Tariff refund cash received, FY$59.1M$60.6M booked in Q3Nearly all collectedAs promised
Net debt$289.9M$374.1M at JuneDown $84.2MBelow our $300M horizon assumption
Net leverage, company / excluding refunds0.77x / 0.91x2.0–2.5x long-term targetDownn/a
Cash / total liquidity$339.9M / $836.2M$258.9M cash at JuneUpn/a
Q4 share repurchases$0$15.9M in Q3; $58.2M for FY26PausedBelow
Interest income, Q4$4.8M$0.6M a year agoUpNot explained in the Q4 release
Inventories$466.0M$446.1M a year ago+4.5%n/a
Fill ratesAbove 95%, all three unitsSame as Q3Stablen/a
Redeemable noncontrolling interest$69.0M$61.8M at JuneUpOur claim reserve: $90M

Key Topics & Management Commentary

Overall Management Tone: Management was assertive about fiscal 2026 and combative about Helen of Troy. The call opened with a prepared case against the target's board and then refused questions on the bid, so the strategic item of the quarter went untested. The fiscal 2027 discussion was measured, with inflation framed as a real cost. Compared with August, the emphasis moved from operating detail to deal advocacy, and only two analysts asked questions.

1. Empower Brands' Helen of Troy bid turns the HPC exit into a build-up

On November 4, Empower Brands made public a $37.00-per-share cash proposal for Helen of Troy, at an implied enterprise value of about $1.6B. Empower first offered $34.00 on August 19 and raised the offer on October 12. Helen of Troy's board rejected both. An Empower affiliate already owns about 4.5% of the target. Funding would come from Empower's cash, new equity from Spectrum and Oaktree, and third-party debt that would not have recourse to Spectrum. The combined platform would have about $2.9B of sales.

"And importantly, it would advance our strategy to unlock and maximize the value of our Home & Personal Care business through a potential spin-off, merger, or sale."
— David Maura, Chairman & CEO

The price is not extreme. An enterprise value of $1.6B is about 7.7x the midpoint of Helen of Troy's own fiscal 2027 EBITDA guide of $203–210M, against roughly 7.5x for Spectrum itself and about 6x for Oaktree's entry into HPC. Helen of Troy's shares closed at $37.32 on November 13, above the offer. That says the market expects a higher price, and management said on the call that a customary NDA "could potentially support an improved proposal." Spectrum has not said how much equity it would contribute. Our illustration assumes 4.0–5.0x combined debt, a pro rata 72.7% share, no use of Empower's existing cash, and no fees. On those assumptions, Spectrum's check would be roughly $180–380M, or $8–16 per Spectrum share. Each extra dollar per Helen of Troy share would cost Spectrum about $16M, or $0.70 per Spectrum share, at that same share.

Assessment: The industrial logic is reasonable: scale matters in small appliances and personal care, and the debt would not sit on Spectrum. But the pillar we underwrote was HPC monetization, meaning value flowing out of HPC to Spectrum holders. This bid sends new Spectrum capital into HPC first and moves the exit behind a larger combination. We move Bull 5 to AT RISK and add a capital-allocation bear. The deal can still create value, but only at a price and equity split that management has not yet shown.

2. The fiscal 2027 framework: flat to low single digits on a higher base

Management guides net sales flat to up low single digits and adjusted EBITDA flat to up low single digits after removing fiscal 2026's refunds. Adjusted free cash flow should again be about 50% of adjusted EBITDA. We read "low single digits" as 0–3%. On the $317.4M base, that gives $317–327M of EBITDA and $2,852–2,938M of sales. Published fiscal 2027 EPS estimates of $5.24–5.37, and one provider's $2.88B of sales, sit near the midpoint.

"Despite that significant headwind, we do expect adjusted EBITDA to be flat to up low-single digits for fiscal 2027 after normalizing for onetime tariff refund benefits received in fiscal 2026."
— David Maura, Chairman & CEO

Assessment: This meets our August request for a supported fiscal 2027 plan. The base is higher than we expected, so a modest growth rate still lands near our prior $320M. Management raised the fiscal 2026 framework twice, which suggests the new range is not a stretch. It straddles our base rather than exceeding it, so it does not by itself justify a higher rating.

3. About $80M of new inflation, to be absorbed mostly through cost

The new cost is the most consequential number in the framework. Management tied it to Iran, oil and shipping rates, plus resin, purchased goods and labor. The offsets are cost programs, lower tariff rates and selective pricing. The $80M equals about 25% of fiscal 2026 EBITDA excluding refunds, so a partial shortfall would erase the guided growth.

"On the input cost side, we are now facing approximately $80 million of additional inflationary headwinds, driven by higher diesel fuel, transportation costs, as well as broader commodity pressures across resins, purchased products, finished goods, and labor."
— David Maura, Chairman & CEO

Management did not split the offset between price, tariff relief and cost. It said only that pricing would be strategic rather than across the board.

Assessment: Spectrum's cost record in fiscal 2026 supports the plan, but the margin for error is thin. Our base assumes the offset is complete. Our downside assumes about $15–20M of it fails, which takes fiscal 2027 EBITDA below fiscal 2026.

4. Garden inventory: the payback landed in Q4, and part of it moves into the first half

The garden decline matched the mechanism we described in August. Retailers bought against a strong April, consumption softened from May through August, and replenishment orders slowed. September improved. Management now expects the overhang to be largely gone in the first half, which is the staging period before the season.

"Weather conditions continued to be unfavorable through August, with POS softness for majority of the quarter before showing improvement in September."
— Faisal Qadir, CFO

Assessment: The payback was a timing cost, and garden still grew 3.9% for the year. The open question is the size of the remaining excess, which management did not quantify. A clean channel at the start of the season is now a condition for our fiscal 2027 garden growth assumption.

5. Pet growth was volume, not price

Management stressed that fiscal 2026 pet and garden growth came from volume. That matters because price-led growth would be harder to repeat with $80M of new cost and retailers resisting increases. Chews, the largest companion-animal category, grew again, and management says it has returned to growth on a 52-week basis.

"Both businesses grew with volume growth across both of their platforms."
— David Maura, Chairman & CEO

Assessment: Volume growth with share gains is the stronger form of recovery. It also gives Spectrum some room to take selective price in fiscal 2027 without losing all of its momentum. We keep the pet pillar on track.

6. HPC: profit discipline ahead of the bid

HPC's 130bps margin gain came while sales fell 3.0% for the year. Management credits lower tariffs, efficiencies and favorable currency. The business enters fiscal 2027 with flat sales guidance and margin pressure from inflation. It is also the platform for the Helen of Troy combination.

"While inflationary headwinds are expected to pressure margins in the year ahead, the deliberate actions we took in fiscal 2026 position us well to navigate the environment with confidence."
— Faisal Qadir, CFO

Assessment: HPC met the profit commitment we tracked. A standalone HPC worth more because it earns more would have been the cleanest path to a separation. A bid that enlarges HPC adds integration risk to a business that has not yet shown it can grow sales.

7. Where the Q4 EBITDA gain came from

Spectrum's adjusted EBITDA starts from net income and adds back taxes, interest expense, depreciation, amortization and listed items. It does not remove interest income or other non-operating expense. In Q4, interest income rose to $4.8M from $0.6M, and other non-operating expense fell to $0.5M from $4.7M. The Q4 release and call did not explain either change. The Q3 10-Q helps: interest income rose with the HPC transaction proceeds, and interest on tariff refunds is booked as other non-operating income when realized. With about $56M of refunds collected in Q4, part of the swing is probably refund interest. The company's figures that exclude refunds do not remove it.

"Adjusted EBITDA was $69.9 million, an increase of $6.5 million, including a $3.2 million reinvestment of tariff refund proceeds back into the supply chain."
— Faisal Qadir, CFO

Built up from operating income, Q4 adjusted EBITDA excluding refund costs was $68.8M, up 1.9%. For the year, the same build gives $311.5M, up 5.0%. The difference between the two bases was $5.9M in fiscal 2026 and $13.6M of swing year over year.

Assessment: The definition is disclosed and consistent, so this is not an accounting problem. It is a valuation problem. A multiple applied to EBITDA that includes interest income counts the cash twice when net debt already deducts that cash. We now value Spectrum on operating EBITDA, and we flag the Q4 growth rate as mostly non-operating.

8. Tax: a negative adjusted rate in Q4, and 27.1% for fiscal 2027

The adjusted tax line was a benefit of about $2.4M in the quarter. For the full year, the adjusted rate was about 28.4%, below the 32.8% assumption given in August. Management guides 27.1% for fiscal 2027, including discrete items and state taxes.

"Adjusted diluted EPS decreased to $1.39, driven by a year-over-year reduction in income tax benefits, partially offset by higher adjusted EBITDA and a reduction in shares outstanding."
— Faisal Qadir, CFO

Assessment: Tax keeps moving the headline. We treat about $0.94 as Q4's normalized adjusted EPS and about $5.00 as fiscal 2026 adjusted EPS excluding refunds. At 27.1%, fiscal 2027 adjusted EPS would be about $5.26 on our EBITDA estimate, at the low end of the $5.24–5.37 range of published estimates.

9. Cash: $188M excluding refunds, and the refunds are in

Operating cash flow from continuing operations rose to $291.0M from $204.1M. Capital spending was $47.8M, below the $50–60M range. Adjusted free cash flow was $247.3M including $59.1M of refunds, or $188.2M without them. Spectrum has now collected nearly all of the $60.6M it booked in Q3, as it promised.

"Excluding this benefit, adjusted free cash flow was $188.2 million or approximately $8 per share, a reflection of the continued improvement and strong execution achieved through disciplined working capital management."
— Faisal Qadir, CFO

Assessment: Conversion of 59% beat the 50% framework, partly from lower receivables and capex. We do not extrapolate it. The fiscal 2027 framework returns to about 50%, or about $161M on our EBITDA estimate, which is a 7.9% yield on today's equity value.

10. Capital allocation: buybacks paused, M&A active

Spectrum bought back no stock in Q4. Fiscal 2026 repurchases of $58.2M all came in the first three quarters, against an authorization of more than $300M. The pause coincides with the Helen of Troy approach, which began in July. Leverage of 0.77x sits far below the 2.0–2.5x long-term target, so the balance sheet has room. Management also said Spectrum was recently outbid on deals in companion animal.

"This strategic opportunity exists precisely because Spectrum is now operating from a position of strength with an unlevered balance sheet."
— David Maura, Chairman & CEO

Assessment: The balance sheet pillar is intact. The capital-return part of it is on hold while management pursues deals. Low leverage is an asset only if it is spent well. Losing pet auctions on price is a good sign, and the Helen of Troy price will test the same discipline.

11. ERP completion: the cost phase ends; savings must now appear

The HPC Europe go-live completed Spectrum's move to a single S/4HANA platform, a commitment we tracked from August. ERP adjustment costs were $12.1M in fiscal 2026. The company's footnote says costs continue through further deployments in calendar 2026. Management now points to process standardization, data quality and AI tools as the next source of efficiency.

"With the recent deployment of S/4HANA in our HPC EMEA business, we are now operating on a single ERP platform across the entire organization."
— David Maura, Chairman & CEO

Assessment: Completion removes an execution risk and should end a recurring adjustment line. Management has not quantified savings, so our fiscal 2027 estimate includes none beyond normal productivity.

Guidance & Outlook

ItemFY26 framework (August)FY26 actualFY27 frameworkChange
Net salesFlat to low-single-digit growth+1.5%Flat to up low single digitsSimilar
Adjusted EBITDA, excluding refundsMid-single-digit growth+9.8% ($317.4M)Flat to up low single digitsSlower growth
Adjusted FCF conversionAbout 50%59.3% excluding refundsAbout 50%Maintained
D&A including share-based compensation$115–125M$122.4M$120–130M (SBC $20–25M)Higher
Capital expenditure$50–60M$47.8M$40–50MLower
Cash taxes$40–50MNot in the release$30–40MLower
Restructuring and strategic cash costs$25–35MNot in the release$20–30MLower
Adjusted EPS tax rate32.8%~28.4% (analyst)27.1%Lower
Long-term net leverage target2.0–2.5x0.77x2.0–2.5xMaintained

The fiscal 2027 range rests on three moving parts. Pet and garden should grow low single digits, with garden's first half soft. HPC should hold flat. Pricing, cost actions and lower tariffs should cover about $80M of inflation, and management plans to spend part of any surplus on brands. Management has given no quarterly shape, but the first half carries the garden overhang and the HPC pull-forward reversal.

Implied path: At the midpoint we use, fiscal 2027 EBITDA of $322M is $4.6M above fiscal 2026. With a soft first half, the second half must grow faster than the year, which puts weight on the garden season and on inflation offsets landing by spring.

Street at: Published fiscal 2027 adjusted EPS estimates of $5.24–5.37, and one provider's $2.88B of sales, sit inside the framework, near its middle. The framework does not force estimates down.

Guidance style: Conservative. Management raised the fiscal 2026 framework twice and still beat it. We treat the upper half of the new range as reachable if inflation stops rising.

Analyst Q&A Highlights

Only two analysts asked questions, after a call that restarted following an audio drop. Their multi-part questions are split by topic below.

How the $80M of inflation gets covered

The first question asked what the plan assumes for pricing and promotion if margins are to hold. Management answered that cost programs will do most of the work, that retailers resist price increases, and that some pricing is still built into the plan.

Q: "First, on the $80 million in incremental inflation, how are you thinking about the potential offsets that result in EBITDA margins plus or minus flattish, presumably mostly focused on productivity initiatives. But what have you embedded for the pricing and promotion environment for fiscal 2027?"
— Olivia Tong, Raymond James

A: "In terms of how we're addressing it, mostly we're going to do this through what we do well: cost improvement initiatives. So it's a lot of automation in the factories, it's a lot of re-engineering of products to make them better but cost less. [...] Retailers don't want us to raise prices. We want to drive volume. [...] Will we have to take some price action? Yes, unfortunately we do. We'll try to be smart about that. But that is all embedded in the outlook, and I think that addresses the first part of your question."
— David Maura, Chairman & CEO

Assessment: The answer confirms the order of the offsets but gives no split. Cost-led offsets are more repeatable than price, but their timing is less certain. The same question also asked about lost shelf space in fiscal 2027, and that part went unanswered.

Aquatics: size and repair plan

The second line asked how large aquatics now is and how Spectrum will stop it from diluting companion-animal growth. Management said aquatics has shrunk to less than 20% of the business from two-thirds a decade ago. It described the North American losses as hard goods, which it does not consider strategic.

Q: "And then specifically for Pet, that continues to be a tale of two cities between companion and aquatics. Companion obviously doing well, aquatics less so. At this point, how big is aquatics? And what's your plan to sort of stabilize the business and minimize its drag to companion?"
— Olivia Tong, Raymond James

A: "The only other thing I'd add on aquatics is that in Europe, we continue to take share, it's just the category has been struggling. And in North America, we have an on-purpose plan to turn the Tetra business around. That's where I think some of our recent struggles have been. But I'll highlight that our losses have been in hard goods, which, like we said before, is not strategic."
— Faisal Qadir, CFO

Assessment: The shrinking weight of aquatics limits the damage. Calling lost distribution non-strategic is a reasonable portfolio view, but it still costs sales in fiscal 2027.

Pet M&A: outbid, and staying disciplined

Asked what role acquisitions could play in pet, management said its M&A focus remains companion animal, and it volunteered that Spectrum had recently lost assets to higher bidders.

Q: "How do you think about the role that M&A could or should play in this?"
— Olivia Tong, Raymond James

A: "So, look, the M&A strategy is going to continue to be around building on the companion animal space. I think everybody knows we're looking hard there, been outbid recently on some stuff. We're going to remain disciplined."
— David Maura, Chairman & CEO

Assessment: Losing auctions on price is consistent with the discipline management claims. It also shows that Spectrum's cash is actively looking for a home, which raises the stakes of each deal decision.

The bid question management would not take

The analyst acknowledged the no-questions rule and asked instead about industry factors behind the deal: overlap in third-party manufacturers and Spectrum's unused capacity. Management declined the specifics and restated the consolidation logic.

Q: "And I know you don't want to talk about the bid, but can you talk about the factors in the HPC industry that, as you think [...] that are driving sort of the desire for a deal, and your willingness to talk about how much overlap there is on third-party manufacturers amongst different companies, your own unutilized capacity as well?"
— Olivia Tong, Raymond James

A: "Look, we're not talking about the call [...] I mean, the deal on this Q&A piece, right? And I was pretty clear on that. [...] There are way too many people selling the same products to very few retailers, and that is not a smart value chain. We are trying to create a win-win situation here. In fact, I would call it a win-win-win."
— David Maura, Chairman & CEO

Assessment: The question asked for the synergy inputs, and the answer gave none. Shareholders who would fund the equity have no synergy figure, no funding split and no price ceiling.

Why HPC is guided flat: the scale argument

Pressed on the drivers behind flat HPC sales, management described a category in which one competitor takes most of the profit and subscale brands cannot fund innovation or digital marketing.

Q: "And then on HPC, I think you said on the call that you're expecting flattish HPC sales for fiscal 2027. So could you talk about the drivers of that?"
— Olivia Tong, Raymond James

A: "I mean, listen, I mean, HPC is competing in an industry where you've got one person with massive resources, massive innovation, and they've probably taken 80% of the profit pool. I mean, you know who that company is. And everybody else is left languishing. And unless you create scale and you have resource where you can actually invest meaningfully into consumer insight-driven innovation and actually spend a lot of money on digital marketing, so you have some share of voice to get to today's consumer, you're simply lost."
— David Maura, Chairman & CEO

Assessment: This is the clearest statement of the deal's rationale on the call. It cuts both ways. If HPC's category is structurally this hard, buying more of it needs a convincing synergy case, and management did not provide one.

The garden innovation pipeline

The second analyst asked whether the garden pipeline that drove this year's growth has more behind it. Management described a pattern: prove the product in year one, then win wider distribution in year two. Liquid fertilizer is now in its second year.

Q: "So I wanted to ask: A, is there more new products coming? How's the pipeline for H&G?"
— Bob Labick, CJS Securities

A: "We make sure that it is successful on the distribution that we garner in the first year, which has been the case for liquid fertilizer. That'll continue to grow in the second year and follow kind of the same process that we followed with our recent launches. Obviously, there are more launches coming. As we get closer to the season, you'll hear us talk about it."
— Faisal Qadir, CFO

Assessment: The second-year distribution step gives fiscal 2027 garden growth a mechanism beyond weather. New launches remain undisclosed until the season.

Pet and HPC innovation, and the direct-to-consumer channel

The follow-up asked whether pet and HPC are catching up to garden. Management rejected the idea that pet lags. For HPC, it said innovation alone moves little volume in a crowded market, and it pointed to direct-to-consumer sales as the new lever.

Q: "And then talk about the process of Pet and HPC catching up, which you had talked about before as well, please."
— Bob Labick, CJS Securities

A: "On the Pet side, I don't think it's accurate to say that they're lagging far behind. [...] But to David's point earlier, that is a very crowded market, and there's only so much your new innovation can drive in terms of incremental volume. But one of the ways that we're innovating in that business is the channels that we use to approach the consumers, and we are now reaching our consumers through new innovative channels, and a different set of consumers really are being reached through our direct-to-consumer channels. It's been very successful in the UK, we're expanding that into continental Europe, and you'll see us expand that into North America too as we go forward."
— Faisal Qadir, CFO

Assessment: Direct-to-consumer expansion is a sensible channel bet, but management gave no size or margin for it. It does not change our flat HPC sales assumption.

What They're NOT Saying

  1. Spectrum's equity check for Helen of Troy: The filings name the funding mix but not the amounts. Spectrum holders cannot size their exposure until the equity split, Empower's leverage and transaction costs are known.
  2. A synergy figure: The proposal cites "expected synergies", but neither it, the open letter nor the investor presentation gives a number. The scale argument needs one before the price can be judged.
  3. A price ceiling: Management offered to sign an NDA that "could potentially support an improved proposal." It did not say what discipline limits a higher bid, while the target already trades above $37.
  4. How much refund interest sits in EBITDA: Interest income rose to $4.8M from $0.6M, and other non-operating expense nearly disappeared. Both sit inside adjusted EBITDA. The Q4 release does not quantify refund interest, so we cannot tell how much of the swing repeats.
  5. The split of the $80M inflation offset: Pricing, tariff relief and cost programs were named without amounts. That makes the framework hard to stress-test.
  6. Shelf space for fiscal 2027: Distribution losses in HPC appliances and aquatics hard goods were acknowledged, but a direct question on fiscal 2027 shelf space went unanswered.
  7. When buybacks resume: Repurchases stopped in Q4, and management did not mention them on the call.

Market Reaction

  • Pre-print setup: SPB closed November 11 at $88.29, up 49.4% year to date, 65.8% over 12 months and 14.4% over 30 days. The 52-week closing range was $51.58–91.57. The S&P 500 was up 11.3% year to date.
  • Bid announcement, November 4: SPB rose 7.7% to $91.57, its 52-week closing high, on 1.03M shares, while the S&P 500 rose 1.6%. Helen of Troy rose 25.4% to $37.04.
  • Reaction session, November 12: SPB opened at $89.99, a 1.9% gap, traded between $86.41 and $92.90, and closed at $88.35, up 0.1%. Volume was 0.6M shares, 1.7 times the 30-day average. The S&P 500 fell 0.4%.
  • Next-day session, November 13: SPB fell 0.6% to $87.85, and the S&P 500 fell 0.4%. From the November 3 close, SPB is up 3.3% against a flat index.
  • Peers on November 12: Central Garden & Pet fell 0.5%, Scotts Miracle-Gro fell 2.0% and Energizer fell 0.6%. Helen of Troy fell 2.1% to $37.19.

A Wide Range With No Net Move

The stock traded as much as 5.2% higher during the session and closed flat. Our interpretation is that buyers responded to the headline EPS beat and the fiscal 2026 cash figures, while the call supplied reasons to wait: a flat-to-low-single-digit plan, $80M of new inflation, and a deal discussion that management would not open to questions. The session alone cannot separate these causes. A flat close on 1.7 times normal volume suggests that the market neither rewarded nor punished the plan.

The Bid Was the Bigger Event

The November 4 move was larger than the print. SPB outperformed the index by about 6 points on the day the Helen of Troy proposal became public. Our reading is that investors welcomed a concrete step toward separating HPC. They had not yet priced how much Spectrum equity the step requires. Through November 13, the stock had kept about 43% of that day's gain in price terms and a little over half of it relative to the index. The market's current verdict on the bid is therefore mildly positive. A higher price or a large equity check would test that verdict.

Street Perspective

Debate: Is the Helen of Troy bid value creation or a capital trap?

Bull view: Consolidation is the only answer to subscale small appliances and personal care. Non-recourse debt limits Spectrum's downside to its equity, and a larger Empower would be easier to spin or sell at a better multiple.

Bear view: Spectrum wants to own less of this category, not more. The target's board refuses to engage, its shares trade above the offer, and every dollar of a higher bid comes partly from Spectrum holders, with no synergy figure to justify it.

Our take: The bear has the better argument until terms appear. At 7.7x the target's own EBITDA guide, the current price is defensible. The risk lies in the next price and the size of Spectrum's share, both unknown.

Debate: Is the fiscal 2027 framework a floor or a ceiling?

Bull view: Management raised fiscal 2026 twice and beat it, so flat to low single digits after absorbing $80M of inflation is a conservative start. Volume growth in pet and garden continues.

Bear view: The new inflation is about a quarter of EBITDA, and the first half has known headwinds. A partial miss on the offsets turns growth into decline.

Our take: We lean to the floor reading, because the fiscal 2026 cost record is strong. We still model the midpoint, since the size of the inflation leaves little room to assume more.

Debate: How much of the earnings improvement is operating?

Bull view: Gross margin rose 160bps for the year excluding refunds, every segment expanded its margin, and adjusted free cash flow excluding refunds was about $8 per share.

Bear view: Q4 EPS came from a tax benefit, and most of Q4's EBITDA growth came from interest income and lower non-operating expense. Operating EBITDA grew 5% for the year, not 10%.

Our take: Both are right about different lines. The cash flow is real and the operating improvement is real, at about half the headline rate. We value the business on that lower rate.

Model Update & Valuation

ItemPrior view (August)Current viewReason
FY26 net sales$2,849M (+1.4%)$2,852.4M actual (+1.5%)Pet ahead, garden slightly behind
FY26 EBITDA excluding refunds$305M (+5.5%)$317.4M actual (+9.8%)Q4 $73.1M vs our $60.7M
FY26 operating-basis EBITDA excluding refundsNot modeled$311.5M (+5.0%)Removes interest income and other non-operating items
FY26 adjusted FCF excluding refunds$152.5M$188.2M actual59% conversion
FY26 adjusted EPS excluding refundsAbout $4.10About $5.00Q4 tax benefit and EBITDA beat
FY27 net salesNot specified$2,895M (+1.5%)Pet and garden +2.5%, HPC flat
FY27 EBITDA, company basis$320M$322M (+1.5%)Framework midpoint
FY27 EBITDA, operating basis (valuation)Not modeled$314MAssumes $8M of net non-operating income
FY27 adjusted EPSNot specifiedAbout $5.2627.1% tax rate, 23.0M diluted shares
FY27 adjusted FCFNot specifiedAbout $161M50% conversion
12-month base value$93.9$93.8Higher base and lower debt, offset by the EBITDA basis change

Our fiscal 2027 sales build grows pet and garden 2.5% each and holds HPC flat. For EBITDA, we assume pet and garden grow roughly with sales, HPC margins slip under inflation, and the $80M of new cost is fully offset. These are analyst assumptions. They include no Helen of Troy combination, no new refunds and no ERP savings beyond normal productivity.

The EPS estimate starts from $322M of EBITDA. We subtract about $31M of interest expense and $125M of depreciation, amortization and share-based compensation, which leaves $166M before tax. At 27.1% tax over 23.0M diluted shares, that is about $5.26 a share.

The 12-month enterprise-to-equity bridge

Valuation inputDownsideBaseUpside
FY27 operating EBITDA$295M$314M$328M
EV / EBITDA7.5x8.0x8.5x
Enterprise value$2,212.5M$2,512M$2,788M
Net debt at the valuation date$290M$255M$220M
Outside HPC equity claim$90M$90M$90M
Common shares23.1M23.1M23.1M
Equity value per share$79.3$93.8$107.3
12-month dividends assumed$1.88$1.88$1.88
Total return from $87.85-7.6%+8.9%+24.3%

The base calculation is ($314M × 8.0 − $255M − $90M) ÷ 23.1M = $93.8 a share. We keep the 8.0x multiple from August. The change is the EBITDA basis. Our August bridge applied the multiple to company-defined EBITDA, which includes interest income, while also deducting net debt, which already credits the cash that earns it. We now remove an assumed $8M of net non-operating income. On the old basis, the base value would be about $96.6. The correction costs about $2.80 a share.

The base net debt assumes about $161M of free cash flow, about $43M of dividends, about $50M of repurchases and about $25M of deal, tax-withholding and other cash costs. That gives about $247M, which we round up to $255M for first-quarter working capital. It includes no Spectrum equity for Helen of Troy. The downside holds net debt near today's level, as cash spent on Empower or other deals adds no value, and assumes $15–20M of the inflation offset fails. The upside needs EBITDA about $9M above the top of the framework, plus some re-rating.

We keep the $90M reserve for Oaktree's claim on HPC, above the $69.0M carrying value. A Helen of Troy deal would change this line and the consolidated debt, so we would rebuild the bridge on definitive terms.

At $87.85, Spectrum trades at about 7.7x our fiscal 2027 operating EBITDA and 7.5x on the company's definition, with a 7.9% free-cash-flow yield and a 2.1% dividend yield.

Rating consequence: A base total return of 8.9% is roughly in line with our 8% S&P 500 hurdle, so the rating stays Hold. The downside is about 8% and the upside about 24%. The rating would move up on a lower entry price (about $80 gives a 20% base return), a clean garden channel by the season, or Helen of Troy terms with a modest Spectrum equity share. It would move down on a materially higher bid funded with large Spectrum equity, or a fiscal 2027 framework cut if the inflation offsets fail.

Thesis Scorecard Post-Earnings

August commitments revisited

Commitment from Q3OutcomeGrade
Raised FY26 EBITDA framework and ~50% FCF conversion+9.8% ($317.4M); 59.3% conversionExceeded
Garden retailer inventory normal before next seasonProgress, "some excess remains"; resolution moved to H1 FY27Partly met
Pet share and consumption through the hard Q4 comparisonNorth America grew; share held or gained; Europe and aquatics fellMet
HPC profit vs the $60M-plus aspiration; separation terms$68.9M excluding refunds; a bid to enlarge HPC, not an exitProfit met; exit deferred
Use of the remaining buyback authorizationNo Q4 repurchases; cash held for dealsPaused
Refunds collected within FY26$59.1M received vs $60.6M bookedMet
HPC Europe ERP go-live later in 2026Completed; one platform company-wideMet
A supported FY27 earnings and inflation frameworkFlat to low single digits; $80M inflation quantifiedMet
Thesis PointStatusNotes
Bull 1: Value vs. peers / FCF machineNeutral (AT RISK, unchanged)Cash beat by about $36M; at 7.7x operating EBITDA, the base return is near the hurdle
Bull 2: Fortress balance sheet & capital returnConfirmed (ON TRACK, unchanged)0.77x leverage and $340M of cash; repurchases paused while deals are pursued
Bull 3: Self-help & margin inflectionConfirmed (ON TRACK, unchanged)FY gross margin +160bps excluding refunds; $80M of inflation is the FY27 test
Bull 4: GPC / H&G growthConfirmed (ON TRACK, unchanged)Both grew for the year on volume; garden overhang moves to H1 FY27
Bull 5: HPC monetization + M&A optionalityChallenged (ON TRACK → AT RISK)Profit target met, but the bid sends Spectrum capital into HPC before any exit
Bear 1: Earnings visibilityNeutral (CONTAINED, unchanged)FY27 framework and inflation are quantified
Bear 2: Macro / consumer softnessNeutral (EMERGING, unchanged)Garden payback arrived as expected; inflation is the new pressure
Bear 3: Valuation cushionConfirmed (MATERIALIZING, unchanged)Base return 8.9% vs an 8% hurdle
Bear 4: Earnings qualityConfirmed (EMERGING → MATERIALIZING)Q4 EPS beat was tax; most Q4 EBITDA growth was non-operating
Bear 5 (new): HPC capital allocationNew (EMERGING)Undisclosed Spectrum equity for a rejected $1.6B bid that may rise

Overall: The operating thesis strengthened, and the strategic thesis became less certain. Spectrum met or beat its fiscal 2026 promises on EBITDA, cash, refunds, ERP and HPC profit, and it gave a credible fiscal 2027 plan. The quarter's headline numbers overstated the operating gain, and the Helen of Troy pursuit replaces a planned HPC exit with a larger HPC investment first. On balance, our value is unchanged. Our bridge range is slightly narrower than in August, but it excludes the Helen of Troy proposal, which widens the real range of outcomes.

Commitments to watch: Helen of Troy terms, including any raised price, Spectrum's equity share, Empower leverage and a synergy figure; the fiscal 2027 framework and about 50% conversion; the $80M inflation offset; garden inventory cleared by the season; pet low-single-digit growth with flat margins and an aquatics turnaround; HPC flat sales after the $7M reversal; any resumption of buybacks; ERP efficiency gains; and the 27.1% tax rate.

Action: Maintain Hold, conviction lowered to 5 from 6. The business is executing, but the base return is in line with the market and the Helen of Troy decision widens the outcome in both directions. We would upgrade on a lower entry price or on deal terms that protect Spectrum's capital. We would downgrade on a materially higher bid funded with large Spectrum equity.

Independence Disclosure As of the publication date, the author holds no position in SPB and has no plans to initiate any position in SPB within the next 72 hours. Aardvark Labs Capital Research maintains a firm-wide policy of not trading any security we cover. No compensation has been received from Spectrum Brands Holdings, Inc. or any affiliated party for this research.